Stargardt's disease

Stargardt's disease is treatable*

Up to now, the diagnosis of Stargardt disease meant an unstoppable, gradual loss of central visual acuity for those affected, as the underlying cells of the retina were considered medically unrecoverable. Today, cell-protective research shows that this degenerative process does not have to be passively accepted. Through specialized biological protocols, it is possible to stabilize the remaining retinal tissue and significantly slow down progressive vision loss.

How we treat Stargardt's disease and what improvements can be achieved*

We offer specialized cell-protective treatments to slow down the progression of vision loss in Stargardt disease and stabilize the remaining retinal tissue as best as possible.

What is the scientific background*

Inherited macular degeneration leads to the loss of retinal pigment epithelial cells (RPE) and a subsequent decline in visual acuity in the central visual field. Regenerative approaches aim to protect and preserve remaining visual cells.

* The contents serve to provide understandable orientation and do not replace individual medical advice. Indication, implementation and chances of success are always personally checked by a doctor.